Almirall

2.87%

Almirall is a global biopharmaceutical company founded in 1943 in Barcelona, Spain. The company is dedicated to researching, developing, manufacturing, and commercializing innovative pharmaceutical and medical products to improve the health and well-being of people worldwide.
The company has a presence in over 70 countries and operates through three main business units: Prescription Medicine, Consumer Health, and Contract Manufacturing. Almirall's Prescription Medicine division focuses on developing and commercializing therapies for dermatology, rheumatology, and respiratory diseases. Their Consumer Health division offers a range of healthcare products such as topical medications, probiotics, and food supplements. The Contract Manufacturing unit provides third-party manufacturing services to other pharmaceutical companies.
Almirall has a strong focus on research and development and has collaborations and partnerships with various academic institutions, research centers, and biotechnology companies. These collaborations allow the company to access new technologies, research platforms, and drug candidates to develop innovative treatments for various diseases.
The company has a diverse portfolio of products and is highly committed to sustainability and ethical practices in its operations. Almirall also has a strong commitment to social responsibility and strives to improve access to quality healthcare for patients worldwide.
In recent years, Almirall has made strategic investments and acquisitions to expand its portfolio and global reach. These include the acquisition of Allergan's dermatology portfolio in the United States and the establishment of a joint venture with WuXi Biologics to develop biologics for dermatological diseases.
Overall, Almirall is a leading biopharmaceutical company with a strong commitment to innovation, sustainability, and improving patients' lives through its products and services.

1. History and experience: Almirall has a long history dating back to 1943 and has over 75 years of experience in the pharmaceutical industry. This extensive experience has helped the company develop a deep understanding of patient needs and healthcare systems.
2. Innovation: Almirall is committed to innovation and invests heavily in research and development, with a strong focus on developing new treatments for dermatological diseases, gastrointestinal disorders, and respiratory conditions. The company also has a dedicated team focused on digital health solutions.
3. Global presence: Almirall has a strong global presence, with a presence in over 70 countries and a commercial footprint in Europe, the United States, Canada, and Mexico.
4. Focus on dermatology: Almirall is a leading dermatology company, with a wide range of products for the treatment of skin conditions such as psoriasis, atopic dermatitis, and acne. The company has a strong pipeline of innovative dermatology products in development.
5. Patient-centric approach: Almirall places a strong emphasis on patient-centricity, with a focus on improving patient outcomes and quality of life. The company works closely with patients and healthcare providers to understand their needs and develop solutions that meet them.
6. Sustainability and social responsibility: Almirall is committed to sustainability and has implemented various initiatives to reduce its environmental impact. The company also takes an active role in community and social responsibility projects, such as supporting patient organizations and promoting health education.
7. Collaborations and partnerships: Almirall collaborates with a variety of partners, including academic institutions, other pharmaceutical companies, and technology companies, to drive innovation and bring new treatments to patients.
8. Diversified portfolio: In addition to its focus on dermatology, Almirall also offers treatments for respiratory conditions and gastrointestinal disorders, providing a diversified portfolio that helps mitigate risks and sustain growth.
9. Strong financial performance: Almirall has a strong financial track record, with steady revenue growth and solid profitability. This allows the company to invest in research and development, strategic partnerships, and other growth opportunities.
10. Commitment to diversity and inclusion: Almirall is committed to promoting diversity and inclusion within the company and in the communities where it operates. The company has programs and initiatives in place to foster an inclusive workplace and promote diversity in leadership positions.

The Almirall company's business model is based on the development, manufacturing, and distribution of pharmaceutical products, particularly in the fields of dermatology, respiratory, and central nervous system disorders. They focus on research and development to bring new and innovative treatments to market, as well as strategic partnerships and acquisitions to expand their product portfolio. They also prioritize sustainability and corporate responsibility in their operations. Additionally, they have a strong global presence and collaborate with various healthcare professionals, patients, and institutions to provide solutions to their customers.

1. Almirall is a pharmaceutical company based in Barcelona, Spain. It was founded in 1943 by Antonio Gallardo Ballart.
2. The name Almirall is a combination of two words: alma (meaning soul in Spanish) and mira (meaning to look in Catalan).
3. The company’s logo features a five-pointed star, which symbolizes the five continents where Almirall has a presence.
4. Almirall initially focused on the production of dermatology and respiratory drugs, but has since expanded its portfolio to include treatments for other conditions such as gastroenterology, pain management, and central nervous system disorders.
5. Almirall has a strong presence in Europe, with commercial operations in 21 countries. It also has a significant presence in the United States and Mexico.
6. In 2004, Almirall formed a strategic research alliance with US-based Forest Laboratories, now a subsidiary of Allergan. This allowed Almirall to gain access to the US market and expanded its global presence.
7. Almirall has a strong commitment to sustainability and has set ambitious environmental and social goals. In 2020, it was recognized by the Dow Jones Sustainability Index for its sustainability performance for the sixth consecutive year.
8. The company has a dedicated research and development team focused on identifying and developing innovative treatments for various diseases and conditions. It has also established partnerships with external research centers to further its research efforts.
9. Almirall has a history of supporting social and cultural initiatives. It is a founding member of BarcelonaTech City, an association that promotes the city of Barcelona as a hub for technological innovation and entrepreneurship.
10. As of 2021, Almirall employs over 2,000 people and had a revenue of 908 million euros in 2020. It continues to be committed to developing and providing innovative treatments to improve the health and well-being of patients worldwide.